OS THERAPIES INCORPORATED

NYSE: OSTX (OS Therapies Incorporated)

Last update: 2 days ago, 2:18AM

1.40

0.02 (1.45%)

Previous Close 1.38
Open 1.39
Volume 316,195
Avg. Volume (3M) 538,718
Market Cap 61,060,456
Price / Book 13.65
52 Weeks Range
1.15 (-17%) — 2.57 (83%)
Earnings Date 14 May 2026
Diluted EPS (TTM) -0.990
Current Ratio (MRQ) 1.16
Operating Cash Flow (TTM) -10.08 M
Levered Free Cash Flow (TTM) -12.28 M
Return on Assets (TTM) -263.81%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Bullish Mixed
Biotechnology (Global) Bullish Mixed
Stock OS Therapies Incorporated - -

AIStockmoo Score

0.0
Analyst Consensus 2.0
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 0.0
Technical Oscillators -2.5
Average 0.00

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
OSTX 61 M - - 13.65
ARMP 472 M - - 2.11
LCTX 426 M - - 8.44
CYBN 359 M - - 2.70
PLX 187 M - - 3.88
IBIO 72 M - - 1.28

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.

Sector Healthcare
Industry Biotechnology
% Held by Insiders 33.38%
% Held by Institutions 1.38%

Ownership

Name Date Shares Held
Cm Management, Llc 31 Dec 2025 400,000
Howard Financial Services, Ltd. 31 Mar 2026 245,436
Sanders Morris Harris Llc 31 Mar 2026 32,000

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria